Akzo Pays $28M To Settle Remeron Suits
Dutch conglomerate company Akzo Nobel and its subsidiary Organon USA have agreed to pay $28 million to settle an antitrust suit brought by three generic drug makers over the company's patent...To view the full article, register now.
Already a subscriber? Click here to view full article